Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D04HLE
|
|||
| Former ID |
DNC001502
|
|||
| Drug Name |
Vitaxin
|
|||
| Indication | Solid tumour/cancer [ICD-11: 2A00-2F9Z; ICD-10: C00-D48; ICD-9: 140-199, 210-229] | Discontinued in Phase 2 | [1] | |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800004890) | |||
| REF 2 | Monoclonal antibodies to alphaVbeta3 (7E3 and LM609) inhibit sickle red blood cell-endothelium interactions induced by platelet-activating factor. Blood. 2000 Jan 15;95(2):368-74. | |||
| REF 3 | Validation and comparison of anti-v3 and anti-v5 rabbit monoclonal versus murine monoclonal antibodies in four different tumor entities.Appl Immunohistochem Mol Morphol.2013 Dec;21(6):553-60. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.